Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Adial Pharmaceuticals, Inc. (ADIL)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Adial Pharmaceuticals, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Adial Pharmaceuticals, Inc. since 2005.
The reporting company's ticker symbol is ADIL. The reporting company's CIK number is 1513525.
The total value of stock buying since 2005 is $238,737.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-03-29||Johnson Bankole A. (Chief Medical Officer)||Buy||33,100||3.41||112,937|
|2019-03-28||Johnson Bankole A. (Chief Medical Officer)||Buy||40,000||3.15||125,800|
|2018-07-31||En Fidecomiso De Mi Vida 11/23/2010 Trust||Buy||1,400||.00||0|
|2018-07-31||Newman James W. Jr.||Buy||20,000||.00||0|
|2018-07-31||Gilliland Robertson H.||Buy||14,000||.00||0|
|2018-07-31||Stilley William B. Iii (Chief Executive Officer)||Buy||80,000||.00||0|
Insider trading activities including stock purchases, stock sales, and option exercises of ADIL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Adial Pharmaceuticals, Inc. (symbol ADIL, CIK number 1513525) see the Securities and Exchange Commission (SEC) website.